Title | Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. |
Publication Type | Journal Article |
Year of Publication | 1994 |
Authors | Newell KJ, Witty JP, Rodgers WH, Matrisian LM |
Journal | Mol Carcinog |
Volume | 10 |
Issue | 4 |
Pagination | 199-206 |
Date Published | 1994 Aug |
ISSN | 0899-1987 |
Keywords | Adenoma, Carcinoma, Colorectal Neoplasms, Extracellular Matrix Proteins, Gene Expression, Glycoproteins, Humans, In Situ Hybridization, Matrix Metalloproteinase 7, Metalloendopeptidases, RNA, Messenger, Tissue Inhibitor of Metalloproteinases |
Abstract | The metalloproteinase matrilysin is widely expressed in the epithelial tumor cells of malignant colorectal adenocarcinomas. Approximately 50% of benign adenomas also express low levels of matrilysin that is focally localized. The expression of stromelysin-1, stromelysin-3, and gelatinase A was observed in the stromal component of several carcinomas and was not present in adenomatous tissue. The expression of interstitial collagenase and gelatinase B was observed in occasional adenomas and carcinomas. Stromelysin-2 transcripts were not detectable in any of the samples examined. Tissue inhibitor of metalloproteinase-1 gene expression was widespread and was observed in both epithelial and stromal cells of adenomas and carcinomas. These results indicate that matrilysin gene expression is an early event in colorectal tumorigenesis and that the expression of stromelysin-1, stromelysin-3, and gelatinase A is primarily a late event. The observed gene expression patterns suggest that matrilysin may participate in early events in tumor progression and that multiple members of the metalloproteinase family may work in concert to facilitate late-stage tumor invasion and metastasis. |
DOI | 10.1002/mc.2940100404 |
Alternate Journal | Mol Carcinog |
PubMed ID | 8068180 |
Grant List | CA46843 / CA / NCI NIH HHS / United States CA60867 / CA / NCI NIH HHS / United States |
Related Faculty:
William Rodgers, M.D., Ph.D.